Amanda Dronzek



Amanda is a Director at Centri Business Consulting. She has more than 12 years of public accounting and industry experience. She joined Centri in December 2023 and supports clients in several industries, focusing primarily on cannabis, life sciences, and technology. Amanda specializes in SEC reporting and technical accounting, providing guidance to clients on various SEC filings and a wide variety of complex transactions.

Prior to Amanda’s time with Centri, she was the Assistant Controller at Albireo Pharma, a publicly traded biotech that invented and commercialized a pharmaceutical for pediatric liver disease. Before joining Albireo Pharma, Amanda held several roles at Danaher, a Fortune 200 life sciences conglomerate, including leading Danaher’s SEC reporting function. Amanda started her career at KPMG and spent over five years supporting audit clients across many industries, including real estate, hospitality, ecommerce, financial services, and not-for-profit entities.

Amanda received a B.A. degree in Economics and Accounting from the College of William and Mary and an M.S. in Accounting from the University of Virginia. She is a Certified Public Accountant (CPA) in the state of Virginia and is a member of the American Institute of Certified Public Accountants (AICPA).